1 asset in Retroperitoneal Cancer
Therapeutic assets addressing Retroperitoneal Cancer, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Eribulin Monomethanesulfonate Retroperitoneal Cancer | OHSU Knight Cancer Institute | P1 | CC (43) |